It's interesting that the 4 arm trial will look at lenz as a Covid therapy for patients that are also suffering from cancer.
But since most Covid deaths are due to inflammation caused by cytokine storm, I hope that this study doesn't pigeon-hole us into only treating cancer-Covid patients. Lenzilumab's Method of Action is the same in treating cytokine storm, regardless of other diseases the patients may have. At least, that is what I gather from the limited clinical data we have seen to date.